Purity specification is an experimental design decision, not a procurement default. The right grade is the one whose residual impurities cannot plausibly affect the readout, which depends on what the assay measures and how sensitive it is to related substances. Over-specifying wastes budget that would produce more value as additional replicates; under-specifying introduces a confound that no amount of statistical treatment removes afterward. This guide maps common research applications to the specification each actually requires.
Start from the failure mode, not the number
The useful question is not how pure the material should be but what a given impurity could do to the measurement. That reframing produces clear answers. If the assay reads a signal that a structurally related impurity could also produce, related substances are a confound and the specification needs to be tight. If the assay measures a bulk physical property, minor related substances are irrelevant and the specification can be loose. If quantitation depends on assuming that vial mass equals compound mass, then non-peptide content, water, salt, and counterion, matters more than the chromatographic figure does, and those are measured by separate assays. Working forward from the failure mode also identifies cases where the standard purity number is simply the wrong specification to be negotiating, which is more common than it appears.
Screening and method development
Exploratory work tolerates the loosest specifications, because its outputs are directional rather than quantitative. Solubility testing, buffer compatibility, stability screening, instrument calibration runs, and preliminary range-finding all ask whether something happens at all, not precisely how much. A 95% to 98% specification is generally appropriate here, and the money saved is better spent on more material, which in early work is usually the binding constraint. Two caveats apply. If a screening result will be carried forward without re-testing on higher-grade material, the loose specification propagates into whatever comes next, so exploratory grade should stay in exploratory work. And if the screen is a sensitive one, a low-concentration binding screen for instance, it belongs in the next category rather than this one despite being labeled screening.
Receptor binding and cell-based assays
This is where specification matters most, because the impurities most likely to be present are the ones most likely to interfere. Deletion sequences and modified variants share most of the target's structure and can bind the same site with reduced affinity, contributing signal rather than diluting it. At a looser specification the related-substance load can be enough to shift a concentration-response curve in the sensitive region. A 99% or better specification is the appropriate baseline, and the chromatogram is worth requesting alongside it, since the profile behind the number determines whether the remainder is inert or active. Batch consistency deserves equal attention in longitudinal work: changing lots mid-study introduces variance that is difficult to distinguish from a real effect, so where possible a single lot should cover a complete experimental series, with the lot number recorded against each dataset.
Structural and analytical reference work
The most demanding applications are those where heterogeneity degrades the measurement directly. Crystallography needs conformational homogeneity to produce ordered lattices, and closely related impurities interfere with that regardless of how small a fraction they represent. NMR structural work suffers from overlapping signals contributed by related species. Material serving as an analytical reference standard, against which other batches are compared, propagates any of its own impurity content into every comparison made with it. These applications call for the highest available specification plus orthogonal characterization, meaning mass spectrometry alongside chromatography and, for sequences with chiral risk, a stereochemical method. A single chromatographic figure is insufficient here not because it is inaccurate but because it does not address the properties that matter.
Quantitative work where mass matters
A distinct case arises whenever calculations equate the mass in a vial with the mass of compound. Chromatographic purity does not support that assumption, because it measures the target's share of UV-detected material and excludes water, salts, and counterions, which do not absorb meaningfully at the detection wavelength. Lyophilized peptides are frequently hygroscopic and can carry appreciable water plus counterion load, so actual peptide content per vial can sit well below the chromatographic purity figure. Work requiring accurate concentration should specify content measures, amino acid analysis or a quantitative nitrogen determination, rather than negotiating the purity percentage upward. Alternatively, concentration can be determined in-house after solubilization, which sidesteps the vial-content question entirely. The general point is that purity and content are different specifications, and asking for a higher purity number does not answer a content question.
Building the decision into sourcing
In practice this becomes a short routine. Identify the assay's sensitivity to related substances, choose the specification from that rather than from habit, and request the chromatogram whenever the answer is anything other than clearly insensitive. Confirm that the documentation resolves to the specific lot being shipped, and keep the lot number with the experimental record so batch effects remain traceable afterward. Where the work is quantitative, specify content measures explicitly rather than assuming purity covers them. The overall effect is to spend specification budget where it changes results and to stop spending it where it does not, which usually means buying tighter for a subset of work and looser for the rest instead of applying one grade across everything. Keeping the resulting documents organized is its own discipline, covered in the guide to COA recordkeeping.
FAQ
Is the highest available purity always the safest choice?
It is generally preferable, other things equal, but it is frequently a poor allocation. Budget spent over-specifying exploratory work usually produces more value as additional material or replicates.
What grade suits receptor binding work?
99% or better as a baseline, with the chromatogram reviewed so the composition of the remainder is known rather than assumed.
Does purity tell me how much peptide is in the vial?
No. Chromatographic purity is a share of UV-detected material and excludes water, salt, and counterion content. Peptide content requires a separate assay such as amino acid analysis.
Should one lot cover an entire study?
Where feasible, yes. Changing lots mid-series introduces impurity-profile variation that is hard to separate from real effects. Where a change is unavoidable, record which lot produced which data.
When are orthogonal methods necessary?
For structural work, reference standards, and any sequence where diastereomers or oxidation are plausible, since chromatography alone can miss both.
Research Use Only: All compounds sold by Onward Aminos are intended exclusively for laboratory research. Not for human or animal consumption. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase.
Stay in the loop
New compounds, research updates & exclusive subscriber deals.
Skip to main content
